Association between use of different antibiotics and trimethoprim resistance: Going beyond the obvious crude association

Journal of Antimicrobial Chemotherapy

Volumn 73, Issue 6, 2018, Pages 1700-1707

  Pouwels, Koen B ^a,b,c   Freeman, Rachel ^a   Muller Pebody, Berit ^a   Rooney, Graeme ^a   Henderson, Katherine L ^a   Robotham, Julie V ^a   Smieszek, Timo ^a,c  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CHLORAMPHENICOL DERIVATIVE; IMIDAZOLE DERIVATIVE; LINCOSAMIDE; MACROLIDE; MONOBACTAM DERIVATIVE; NITROFURAN DERIVATIVE; NITROFURANTOIN; PENICILLIN DERIVATIVE; POLYMYXIN; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLONE DERIVATIVE; STEROID; STREPTOGRAMIN DERIVATIVE; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM; TRIMETHOPRIM DERIVATIVE;

ARTICLE; ELASTIC TISSUE; ENGLAND; ENTEROBACTERIACEAE; GEOGRAPHICAL VARIATION (SPECIES); HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; POISSON DISTRIBUTION; PRESCRIPTION; PRIMARY MEDICAL CARE; RISK FACTOR; TRIMETHOPRIM RESISTANCE; URINE SAMPLING; CLINICAL PRACTICE; DRUG EFFECT; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; REGRESSION ANALYSIS; URINARY TRACT INFECTION; URINE;

AMPICILLIN; ANTI-BACTERIAL AGENTS; ENGLAND; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; HUMANS; MICROBIAL SENSITIVITY TESTS; NITROFURANTOIN; PENICILLINS; PRACTICE PATTERNS, PHYSICIANS'; REGRESSION ANALYSIS; TRIMETHOPRIM; TRIMETHOPRIM RESISTANCE; URINARY TRACT INFECTIONS;

EID: 85048141842     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dky031     Document Type: Article

References (37)

1. Costelloe C, Metcalfe C, Lovering A et al. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic reviewandmeta-analysis. BMJ 2010; 340: c2096
2. Goossens H, Ferech M, Vander SR et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: 579-87
3. Garcia-Rey C, Fenoll A, Aguilar L et al. Effect of social and climatological factors on antimicrobial use and Streptococcus pneumoniae resistance in different provinces in Spain. J Antimicrob Chemother 2004; 54: 465-71
4. Priest P, Yudkin P, McNulty C et al. Antibacterial prescribing and antibacterial resistance in English general practice: cross sectional study. BMJ 2001; 323: 1037-41
5. Magee JT, Pritchard EL, Fitzgerald KA et al. Antibiotic prescribing and antibiotic resistance in community practice: retrospective study, 1996-8. BMJ 1999; 319: 1239-40
6. Lipsitch M, Samore MH. Antimicrobial use and antimicrobial resistance: a population perspective.Emerg Infect Dis 2002; 8: 347-54
7. Kahlmeter G, Menday P. Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections. J Antimicrob Chemother 2003; 52: 128-31
8. Amyes SG. The success of plasmid-encoded resistance genes in clinical bacteria. An examination of plasmid-mediated ampicillin and trimethoprim resistance genes and their resistancemechanisms.J MedMicrobiol 1989; 28: 73-83
9. Kahlmeter G, Poulsen HO. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO.SENS study revisited. Int J Antimicrob Agents 2012; 39: 45-51
10. Van de Sande-Bruinsma N, Grundmann H, Verloo D et al. Antimicrobial drug use and resistance in Europe. Emerg Infect Dis 2008; 14: 1722-30
11. Blommaert A, Marais C, Hens N et al. Determinants of between-country differences in ambulatory antibiotic use and antibiotic resistance in Europe: a longitudinal observational study. J Antimicrob Chemother 2014; 69: 535-47
12. Donnan PT, Wei L, Steinke DT et al. Presence of bacteriuria caused by trimethoprim resistant bacteria in patients prescribed antibiotics: multilevel modelwith practice and individual data. BMJ 2004; 328: 1297
13. Vellinga A, Murphy AW, Hannahoe B et al.Amultilevelanalysis of trimethoprim and ciprofloxacin prescribing and resistance of uropathogenic Escherichia coli in general practice. J Antimicrob Chemother 2010; 65: 1514-20
14. Bergman M, Nyberg ST, Huovinen P et al. Association between antimicrobial consumption and resistance in Escherichia coli. Antimicrob Agents Chemother 2009; 53: 912-7
15. Greenland S, Mansournia MA, Altman DG. Sparse data bias: a problem hiding in plain sight. BMJ 2016; 352: i1981
16. Zou H, Hastie T. Regularization and variable selection via the elastic net. J R Stat Soc Ser B StatMethodol 2005; 67: 301-20
17. Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linearmodels via coordinate descent. J Stat Soft 2010; 33: 1-22
18. Elith J, Leathwick JR, Hastie T. A working guide to boosted regression trees.JAnimEcol 2008; 77: 802-13
19. Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc Ser B Stat Methodol 1996; 58: 267-88
20. Hoerl AE, Kennard RW. Ridge regression: biased estimation for nonorthogonal problems. Technometrics 1970; 12: 55
21. Greenland S. Invited commentary: variable selection versus shrinkage in the control of multiple confounders. Am J Epidemiol 2008; 167: 523-9. discussion 530-1
22. Hastie T, Qian J. Glmnet Vignette. https://web.stanford.edu/hastie/glmnet/glmnet_alpha.html
23. Ternes N, Rotolo F, Michiels S. Empirical extensions of the lasso penalty to reduce the false discovery rate in high-dimensional Cox regression models. StatistMed 2016; 35: 2561-73
24. Hayes T, Usami S, Jacobucci R et al. Using classification and regression trees (CART) and randomforests to analyze attrition: results fromtwosimulations. Psychol Aging 2015; 30: 911-29
25. Friedman J, Hastie T, Rosset S et al. Discussion of boosting papers. Ann Stat 2004; 32: 102-7
26. Miller PJ, McArtor DB, Lubke GH. metboost: Exploratory Regression Analysis With Hierarchically Clustered Data. arXiv 2017. https://arxiv.org/pdf/1702.03994.pdf
27. Elith J, Leathwick J. Boosted Regression Trees for Ecological Modeling. https://cran.r-project.org/web/packages/dismo/vignettes/brt.pdf
28. Huttner A, Verhaegh EM, Harbarth S et al. Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials. J Antimicrob Chemother 2015; 70: 2456-64
29. Pouwels KB, Visser ST, Bos HJ et al. Angiotensin-converting enzyme inhibitor treatment and the development of urinary tract infections: a prescription sequence symmetry analysis. Drug Saf 2013; 36: 1079-86
30. Pouwels KB, Visser ST, Hak E. Effect of pravastatin and fosinopril on recurrent urinary tract infections.JAntimicrobChemother 2013; 68: 708-14
31. Dolk FCK, Pouwels KB, Smith DRM et al. Antibiotics in primary care in England: which antibiotics are prescribed and for which conditions? J Antimicrob Chemother 2018; 73 Suppl 2: ii2-ii10
32. Rosello A, Pouwels KB, Domenech de CellesMet al. Seasonality of urinary tract infections in the United Kingdomin different age groups, analysis of The Health Improvement Network (THIN). Epidemiol Infect 2018; 146: 37-45
33. Sandegren L, Lindqvist A, Kahlmeter G et al. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli. J Antimicrob Chemother 2008; 62: 495-503
34. Sundqvist M, Geli P, Andersson DI et al. Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use. JAntimicrobChemother 2010; 65: 350-60
35. Pouwels KB, Batra R, Patel A et al. Will co-trimoxazole resistance rates ever go down? Resistance rates remain high despite decades of reduced cotrimoxazole consumption. J Glob Antimicrob Resist 2017; 11: 71-4
36. PHE. Managing Common Infections: Guidance for Primary Care. 2017. https://www.gov.uk/government/publications/managing-common-infections-guidance-for-primary-care
37. PHE. English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Report 2016. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/575626/ESPAUR_Report_2016.pdf